Clinical Trials Directory

Trials / Completed

CompletedNCT02487537

Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
German Institute of Human Nutrition · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. Data on human subjects are sparse and controversial, especially in a long-term manner. We therefore conduct a cross-over study to assess metabolic response to sweetened vs. non-sweetened soft drinks, which are consumed over a period of 4 weeks.

Detailed description

Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. Data on human subjects are sparse and controversial, especially in a long-term manner. We therefore conduct a cross-over study to assess metabolic response to sweetened vs. non-sweetened soft drinks, which are consumed over a period of 4 weeks. Metabolic assessment will be based on oral glucose tolerance tests.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcustom-made soft drink

Timeline

Start date
2015-03-01
Primary completion
2017-06-01
Completion
2019-07-01
First posted
2015-07-01
Last updated
2020-06-24

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02487537. Inclusion in this directory is not an endorsement.